Co Dx provides on‑site, real‑time PCR platforms that enable laboratories, point‑of‑care clinics, hospitals and even at‑home users to run multiplexed infectious‑disease tests without sending samples to a central lab.
Funding
$7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Access to rapid, multiplexed PCR testing is limited by the need for centralized laboratories, specialized equipment, and trained personnel, causing delays in diagnosing infectious diseases and hindering timely public health responses.
Solution
Co‑Dx delivers on‑site, real‑time PCR platforms that enable laboratories, healthcare facilities, and at‑home users to perform multiplexed infectious‑disease assays without sending samples to external labs. The system combines proprietary Co‑Primers® chemistry with advanced color‑based detection and melting‑curve analysis to generate reliable results within minutes. Integrated software guides users through sample preparation, runs the assay, and provides immediate, encrypted results that can be accessed via a web dashboard or exported to electronic health records. By offering both in‑vitro diagnostic (IVD) kits compliant with local regulations and research‑use‑only (RUO) kits, Co‑Dx supports clinical diagnostics as well as academic and industry research workflows.
Target Audience
Primary customers include clinical laboratories, hospitals, point‑of‑care clinics, and enterprises that need rapid on‑site infectious‑disease testing, as well as research institutions and vector‑control agencies requiring multiplex PCR assays.
Features
- Stand‑alone PCR instrument (Co‑Dx™ PCR Pro) with built‑in thermal cycling and optical detection for real‑time multiplex assays
- Proprietary Co‑Primers® technology that enhances specificity and enables simultaneous detection of multiple pathogens in a single reaction
- Color chemistry and melting‑analysis readout for rapid, quantitative results without the need for fluorescent probes
- Cloud‑connected software that automates assay setup, monitors run performance, and delivers encrypted results to a secure dashboard
- Compatibility with both FDA‑authorized IVD kits and RUO research kits covering COVID‑19, TB, HPV, flu, RSV, Zika, dengue, chikungunya, and other targets
- Vector‑control test kits with built‑in positive controls for mosquito sample analysis
- Modular test cup format (Co‑Dx PCR Test Cups) for easy sample loading and reduced contamination risk